top of page

Austin Westerman-Gritli PhD

Managing Director

Austin brings a wealth of knowledge and experience to his role at Cross-Pacific Pharma Connect, having spent over ten years working closely with pharmaceutical companies and CROs in Japan.

 

With a Master’s degree in Medical Science from the Karolinska Institute and a PhD in Medicine from the University of Tokyo, he has a strong foundation in both the scientific and cultural nuances essential for successful pharmaceutical development and clinical trial management in Japan.

 

Austin’s strong management skills ensures that the company’s services align with the highest standards of scientific integrity and cultural sensitivity.

Kazu Sasaki, PharmD

Regulatory Advisor

With an impressive career spanning 45 years in drug development, Kazu Sasaki is a veteran pharmacist and an expert in managing diverse clinical programs. His vast experience covers a wide range of therapeutic areas, from oncology to cardiovascular and dermatology, among others. Kazu has been pivotal in representing Japanese clinical operations on global platforms, particularly in navigating PMDA consultations and leading major clinical development initiatives. As head of the ICCC team, he has successfully managed over 30 CTNs, showcasing his proficiency in meeting stringent regulatory standards and leading complex projects to success.

Yuji Karasuyama

Head of Clinical Operations and Pharmacovigilance

​Yuji Karasuyama has dedicated 25 years to the field of clinical development, holding pivotal roles in both pharmaceutical companies and CROs. His expertise as a safety manager is reflected in his management of over 30 ICCC projects and more than 10 Phase I studies in Australia. Yuji’s strategic acumen was instrumental in the marketing authorization of two innovative products in Japan, overseeing their development from protocol creation through to PMDA inspections. His current roles as Japan BD head and IMP Manager at a global CRO highlight his diverse skill set, including his ability to support Investigator Initiated Trials with comprehensive regulatory, medical writing, and project management services.

©2025 by  Cross-Pacific Pharma Connect AB. 

bottom of page